DRRX

Durect Corp

A biopharmaceutical company focused on drug-delivery and treatments for serious liver conditions, DURECT is developing larsucosterol for alcohol-associated hepatitis and sells Posimir, a non-opioid pain reliever delivered through its SABER technology. Founded in 1998 in Cupertino, California, the company's name reflects its mission to put "the right drug to the right site in the right amount at the right time," and its early work centered on the Duros system, a tiny implantable titanium osmotic pump that steadily releases medication for months at a time.

Recent Activity

Show $

2019Q3

1 sell

First Eagle Investment ManagementEXIT

-26.48M shares

First Eagle Investment ManagementEXIT

-26.48M shares

2019Q2

1 buy

First Eagle Investment ManagementADD

+4.00M shares(+17.8%)

First Eagle Investment ManagementADD

+4.00M shares(+17.8%)

Loading more activity...